Aperta Biosciences, LLC
Aperta Biosciences, LLC
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis. | blepharitis, eye disorder, eyelid disorder | Active, not recruiting | Phase 2 | 2026-05-19 | NCT06720896 |